APA (7th ed.) Citation

Busse, W. W., Katial, R., Gossage, D., Sari, S., Wang, B., Kolbeck, R., . . . Molfino, N. A. (2010). Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti–IL-5 receptor α antibody, in a phase I study of subjects with mild asthma. Journal of allergy and clinical immunology, 125(6), 1237-1244.e2. https://doi.org/10.1016/j.jaci.2010.04.005

Chicago Style (17th ed.) Citation

Busse, William W., et al. "Safety Profile, Pharmacokinetics, and Biologic Activity of MEDI-563, an Anti–IL-5 Receptor α Antibody, in a Phase I Study of Subjects with Mild Asthma." Journal of Allergy and Clinical Immunology 125, no. 6 (2010): 1237-1244.e2. https://doi.org/10.1016/j.jaci.2010.04.005.

MLA (9th ed.) Citation

Busse, William W., et al. "Safety Profile, Pharmacokinetics, and Biologic Activity of MEDI-563, an Anti–IL-5 Receptor α Antibody, in a Phase I Study of Subjects with Mild Asthma." Journal of Allergy and Clinical Immunology, vol. 125, no. 6, 2010, pp. 1237-1244.e2, https://doi.org/10.1016/j.jaci.2010.04.005.